Article
Pooled screening of CAR T cells identifies non-native signaling domains for next-generation immunotherapies
2021-07-12
Abstract excerpt
<h4>SUMMARY</h4> Chimeric antigen receptors (CARs) repurpose natural signaling components to retarget T cells to refractory cancers, but have shown limited efficacy against solid tumors. Here, we introduce ‘CAR Pooling’, a multiplexed approach to rapidly identify CAR designs with clinical potential. Forty CARs with diverse immune costimulatory domains were assessed in pooled assays for their ability to stimulate...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 15ff28db-8e5f-55c2-b07b-650f3f2214cb
- DOI
- 10.1101/2021.07.11.451980
